Rakhma Yanti Hellmi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rakhma Yanti Hellmi has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Ana Monica Estrella
Makati Medical Center Makati Philippines
1 shared publication - Binit Vaidya
National Center for Rheumatic Diseases Kathmandu Nepal
1 shared publication - Charles Limantoro1 shared publication
Claire Teo
Tan Tock Seng Hospital Singapore Singapore
1 shared publicationDimitra Micha
Department of Human Genetics, Amsterdam Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam UMC, Location VU University Medical Center, Amsterdam, The Netherlands
1 shared publicationDody Tri Permadi
1 shared publication
Latest Publications
- 23 October 2026
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 29 (10)
Development and Preliminary Psychometric Validation of the Gout Knowledge, Attitudes and Practices (G‐KAP) Questionnaire: An Asia‐Pacific Multicenter Study
Aim: To develop and undertake preliminary psychometric validation of the Gout Knowledge, Attitudes and Practices (G‐KAP) Questionnaire for patients with gout in multiple Asia‐Pacific clinical settings. Methods: Six development experts and nine relevance experts reviewed the English 56‐question instrument. Analyses included 312 baseline participants from 10 countries and 117 paired assessments; 149 participants formed an additional recruitment‐wave subset. Language assistance involved oral explanation without a fixed translation script. We evaluated content relevance, keyed knowledge reliability, item‐level stability, and exploratory structure using explicit coding and missing‐data rules. Results: S‐CVI/Ave was 0.998 across 68 rated rows. The 19‐indicator knowledge score averaged 56.1% ± 20.3%; KR‐20 was 0.770 and common‐factor omega 0.764. Absolute‐agreement single‐measure ICC was 0.763 (95% bootstrap CI 0.635–0.857); mean retest increase was 2.34 percentage points ( p = 0.037). Numeric attitude ICCs ranged 0.345–0.838. Among 303 complete cases for 38 exploratory indicators, full‐matrix and common‐factor parallel analyses suggested 7 and 11 dimensions. The seven‐factor comparison model included two weak two‐item factors and ambiguous cross‐loadings. Conclusion: The English G‐KAP shows strong expert‐rated relevance and encouraging preliminary knowledge‐score reliability. Oral‐assistance variability, unequal recruitment and uncertain dimensionality limit interpretation. Cross‐cultural validity, measurement invariance, attitude/practice composite scores and clinical effectiveness are unestablished. Standardized administration, linguistic adaptation and independent confirmatory evaluation are needed before cross‐country comparison or subscale development.
- 23 October 2026
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 29 (10)
Development and Preliminary Psychometric Validation of the Gout Knowledge, Attitudes and Practices (G‐KAP) Questionnaire: An Asia‐Pacific Multicenter Study
Aim: To develop and undertake preliminary psychometric validation of the Gout Knowledge, Attitudes and Practices (G‐KAP) Questionnaire for patients with gout in multiple Asia‐Pacific clinical settings. Methods: Six development experts and nine relevance experts reviewed the English 56‐question instrument. Analyses included 312 baseline participants from 10 countries and 117 paired assessments; 149 participants formed an additional recruitment‐wave subset. Language assistance involved oral explanation without a fixed translation script. We evaluated content relevance, keyed knowledge reliability, item‐level stability, and exploratory structure using explicit coding and missing‐data rules. Results: S‐CVI/Ave was 0.998 across 68 rated rows. The 19‐indicator knowledge score averaged 56.1% ± 20.3%; KR‐20 was 0.770 and common‐factor omega 0.764. Absolute‐agreement single‐measure ICC was 0.763 (95% bootstrap CI 0.635–0.857); mean retest increase was 2.34 percentage points ( p = 0.037). Numeric attitude ICCs ranged 0.345–0.838. Among 303 complete cases for 38 exploratory indicators, full‐matrix and common‐factor parallel analyses suggested 7 and 11 dimensions. The seven‐factor comparison model included two weak two‐item factors and ambiguous cross‐loadings. Conclusion: The English G‐KAP shows strong expert‐rated relevance and encouraging preliminary knowledge‐score reliability. Oral‐assistance variability, unequal recruitment and uncertain dimensionality limit interpretation. Cross‐cultural validity, measurement invariance, attitude/practice composite scores and clinical effectiveness are unestablished. Standardized administration, linguistic adaptation and independent confirmatory evaluation are needed before cross‐country comparison or subscale development.
- Open Access
- 15 September 2026
- Published by SAGE Publications in Indian Journal of Rheumatology
Intravenous Cyclophosphamide Infusion and miRNA-29A, miRNA-16, IL-6, TGF-β1 Responses in Systemic Sclerosis Patients with Interstitial Lung Disease
Background: Systemic sclerosis (SSc) is characterised by organ fibrosis, microvascular damage and immunological dysregulation. With an aetiology that remains poorly understood, increasing evidence suggests that epigenetic alterations and inflammatory mechanisms play crucial roles in the pathogenesis of SSc. Objective: To evaluate the effects of intravenous cyclophosphamide (CYC) versus conventional disease-modifying antirheumatic drugs (DMARDs) on miRNA-29a, miRNA-16, interleukin-6 (IL-6) and transforming growth factor-beta 1 (TGF-β1) levels in SSc-associated interstitial lung disease (SSc-ILD). Methods: This quasi-experimental study included 67 patients meeting the 2013 American College of Rheumatology/European League Against Rheumatism criteria with high-resolution computed tomography-confirmed ILD. Treatment allocation was not randomised; patients received either intravenous CYC ( n = 32) or conventional DMARDs ( n = 35) based on clinical indications. Serum miRNA-29a, miRNA-16, IL-6, TGF-β1 and forced vital capacity (FVC) were quantified at baseline and 6 months. Results: Modulations in miRNA-29a and miRNA-16 were not statistically significant ( P > .05). However, IL-6 significantly declined in both CYC ( P = .001) and DMARD ( P = .019) groups, although the difference between groups was not statistically significant ( P = .051). TGF-β1 levels also decreased significantly across the study population ( P = .004). These shifts were accompanied by highly significant intragroup FVC improvements ( P < .001). FVC improved from 51.35% to 78.75% in the CYC group and from 83.20% to 96.30% in the DMARD group, with no significant intergroup difference ( P = .099). Conclusion: Intravenous CYC substantially reduces TGF-β1 and IL-6 in SSc-ILD, effectively attenuating systemic inflammatory and fibrotic drivers. While CYC demonstrated a stronger trend in IL-6 suppression compared to DMARDs, it did not significantly modulate upstream epigenetic precursors, such as miRNA-29a and miRNA-16.
- 15 September 2026
- Published by SAGE Publications in Indian Journal of Rheumatology
Open AccessIntravenous Cyclophosphamide Infusion and miRNA-29A, miRNA-16, IL-6, TGF-β1 Responses in Systemic Sclerosis Patients with Interstitial Lung Disease
Background: Systemic sclerosis (SSc) is characterised by organ fibrosis, microvascular damage and immunological dysregulation. With an aetiology that remains poorly understood, increasing evidence suggests that epigenetic alterations and inflammatory mechanisms play crucial roles in the pathogenesis of SSc. Objective: To evaluate the effects of intravenous cyclophosphamide (CYC) versus conventional disease-modifying antirheumatic drugs (DMARDs) on miRNA-29a, miRNA-16, interleukin-6 (IL-6) and transforming growth factor-beta 1 (TGF-β1) levels in SSc-associated interstitial lung disease (SSc-ILD). Methods: This quasi-experimental study included 67 patients meeting the 2013 American College of Rheumatology/European League Against Rheumatism criteria with high-resolution computed tomography-confirmed ILD. Treatment allocation was not randomised; patients received either intravenous CYC ( n = 32) or conventional DMARDs ( n = 35) based on clinical indications. Serum miRNA-29a, miRNA-16, IL-6, TGF-β1 and forced vital capacity (FVC) were quantified at baseline and 6 months. Results: Modulations in miRNA-29a and miRNA-16 were not statistically significant ( P > .05). However, IL-6 significantly declined in both CYC ( P = .001) and DMARD ( P = .019) groups, although the difference between groups was not statistically significant ( P = .051). TGF-β1 levels also decreased significantly across the study population ( P = .004). These shifts were accompanied by highly significant intragroup FVC improvements ( P < .001). FVC improved from 51.35% to 78.75% in the CYC group and from 83.20% to 96.30% in the DMARD group, with no significant intergroup difference ( P = .099). Conclusion: Intravenous CYC substantially reduces TGF-β1 and IL-6 in SSc-ILD, effectively attenuating systemic inflammatory and fibrotic drivers. While CYC demonstrated a stronger trend in IL-6 suppression compared to DMARDs, it did not significantly modulate upstream epigenetic precursors, such as miRNA-29a and miRNA-16.
- Open Access
- 31 July 2026
- Published by RSUP Dr. Kariadi Semarang in Medica Hospitalia : Journal of Clinical Medicine
- Vol. 13 (2) , 136-145
Association Of C-Reactive Protein And Modified Rodnan Skin Score With Carotid Intima-Media Thickness in Systemic Sclerosis
BACKGROUND: Systemic sclerosis (SSc) is a chronic autoimmune disease characterized by vasculopathy and progressive fibrosis with an increased risk of cardiovascular disease. The common carotid artery intima-media thickness is an indicator of subclinical atherosclerosis and may reflect inflammatory activity in SSc. Quantitative C-reactive protein (CRP) and the modified Rodnan Skin Score (mRSS) are associated with SSc disease activity, although their relationship with common carotid intima-media thickness remains unclear. AIMS: To evaluate the relationship between quantitative CRP levels and mRSS values with common carotid intima-media thickness in adult patients with SSc. METHOD: A cross-sectional study was conducted on 26 SSc patients at Dr. Kariadi General Hospital, Semarang. Common carotid intima-media thickness was measured using ultrasonography on both sides. Subjects were categorized based on the presence of intima-media thickening according to the ≥75th percentile for age and sex. Quantitative CRP levels were analyzed using the Mann-Whitney test, while differences in mRSS were analyzed using an independent T-test. RESULT: Increased common CIMT was observed in 9 patients (34.6%). There was no significant difference in quantitative CRP levels between subjects without and with intima-media thickening (0.40 [0.07–1.10] vs. 0.40 [0.20–0.83] mg/L; P = 0.787). mRSS values also did not differ significantly between the two groups (18.29 ± 9.38 vs. 18.78 ± 12.48; P = 0.912). CONCLUSION: There was no significant relationship between quantitative CRP levels or mRSS values and common carotid intima-media thickness in patients with SSc. These findings may be influenced by immunosuppressive therapy and study design.
- 31 July 2026
- Published by RSUP Dr. Kariadi Semarang in Medica Hospitalia : Journal of Clinical Medicine
- Vol. 13 (2) , 136-145
Open AccessAssociation Of C-Reactive Protein And Modified Rodnan Skin Score With Carotid Intima-Media Thickness in Systemic Sclerosis
BACKGROUND: Systemic sclerosis (SSc) is a chronic autoimmune disease characterized by vasculopathy and progressive fibrosis with an increased risk of cardiovascular disease. The common carotid artery intima-media thickness is an indicator of subclinical atherosclerosis and may reflect inflammatory activity in SSc. Quantitative C-reactive protein (CRP) and the modified Rodnan Skin Score (mRSS) are associated with SSc disease activity, although their relationship with common carotid intima-media thickness remains unclear. AIMS: To evaluate the relationship between quantitative CRP levels and mRSS values with common carotid intima-media thickness in adult patients with SSc. METHOD: A cross-sectional study was conducted on 26 SSc patients at Dr. Kariadi General Hospital, Semarang. Common carotid intima-media thickness was measured using ultrasonography on both sides. Subjects were categorized based on the presence of intima-media thickening according to the ≥75th percentile for age and sex. Quantitative CRP levels were analyzed using the Mann-Whitney test, while differences in mRSS were analyzed using an independent T-test. RESULT: Increased common CIMT was observed in 9 patients (34.6%). There was no significant difference in quantitative CRP levels between subjects without and with intima-media thickening (0.40 [0.07–1.10] vs. 0.40 [0.20–0.83] mg/L; P = 0.787). mRSS values also did not differ significantly between the two groups (18.29 ± 9.38 vs. 18.78 ± 12.48; P = 0.912). CONCLUSION: There was no significant relationship between quantitative CRP levels or mRSS values and common carotid intima-media thickness in patients with SSc. These findings may be influenced by immunosuppressive therapy and study design.
- Open Access
- 6 October 2022
- Published by S. Karger AG in Case Reports in Dermatology
- Vol. 14 (3) , 291-301
Epidermolysis Bullosa and Rickets in a 21-Year-Old Female: A Case Report
Epidermolysis bullosa (EB) is a group of rare genetic diseases that exhibit mechanical fragility of the skin. This condition will result in the occurrence of skin blisters, skin erosions, and skin ulcerations when the skin is subjected to trauma. In this case report, we present a case of EB and multiple skeletal deformities in a 21-year-old female. She came to our clinic with recurrent skin exfoliations and blisters that occurred since she was 4 years old and multiple bones bowing since she was 9 years old. On physical examinations, we found generalized hypopigmentation macule with erythematous skin. There were numerous bullae and crusted lesions, with erosion and excoriations on the lesions. Laboratory examinations identified low vitamin D 25-OH (8.6 ng/mL). Bone densitometry measurement found low bone density, and X-ray examination found osteopenia and bone bowing. Using whole-exome sequencing, no causative pathogenic sequence or copy number variants in the genes associated with Mendelian inherited disorders were detected. The low levels of vitamin D 25-OH may most likely be the main reason for the occurrence of rickets in this patient aside from the genetic disorder.
- 6 October 2022
- Published by S. Karger AG in Case Reports in Dermatology
- Vol. 14 (3) , 291-301
Open AccessEpidermolysis Bullosa and Rickets in a 21-Year-Old Female: A Case Report
Epidermolysis bullosa (EB) is a group of rare genetic diseases that exhibit mechanical fragility of the skin. This condition will result in the occurrence of skin blisters, skin erosions, and skin ulcerations when the skin is subjected to trauma. In this case report, we present a case of EB and multiple skeletal deformities in a 21-year-old female. She came to our clinic with recurrent skin exfoliations and blisters that occurred since she was 4 years old and multiple bones bowing since she was 9 years old. On physical examinations, we found generalized hypopigmentation macule with erythematous skin. There were numerous bullae and crusted lesions, with erosion and excoriations on the lesions. Laboratory examinations identified low vitamin D 25-OH (8.6 ng/mL). Bone densitometry measurement found low bone density, and X-ray examination found osteopenia and bone bowing. Using whole-exome sequencing, no causative pathogenic sequence or copy number variants in the genes associated with Mendelian inherited disorders were detected. The low levels of vitamin D 25-OH may most likely be the main reason for the occurrence of rickets in this patient aside from the genetic disorder.